Accueil › Annuaire des chercheurs › Fredrick Sawe

Fredrick Sawe

Affiliation : Kenya Medical Research Institute · United States Army Medical Research Directorate - Africa

• 14Publications (affiliation kényane)

OpenAlex

Publications (14)

• Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection
  2026 · Nature Communications · cité 7 fois
• Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
  2024 · Nature Communications · cité 38 fois
• Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
  2023 · The Lancet Respiratory Medicine · cité 25 fois
• Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study
  2023 · EClinicalMedicine · cité 11 fois
• The effects of revised peer-counselor support on the PMTCT cascade of care: results from a cluster-randomized trial in Kenya (the EMMA study)
  2023 · BMC Infectious Diseases · cité 8 fois
• Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia
  2019 · Clinical Infectious Diseases · cité 68 fois
• The Enhanced Mentor Mother ProgrAm (EMMA) for the prevention of mother-to-child transmission of HIV in Kenya: study protocol for a cluster randomized controlled trial
  2018 · Trials · cité 18 fois
• Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya
  2018 · PLoS ONE · cité 16 fois
• Diagnosis disclosure to adolescents living with HIV in rural Kenya improves antiretroviral therapy adherence and immunologic outcomes: A retrospective cohort study
  2017 · PLoS ONE · cité 47 fois
• Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost
  2017 · The Journal of Infectious Diseases · cité 28 fois
• Cardiovascular Disease Risk Factors in HIV-Infected Women After Initiation of Lopinavir/Ritonavir- and Nevirapine-Based Antiretroviral Therapy in Sub-Saharan Africa
  2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes · cité 18 fois
• ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics
  2013 · Journal of the International AIDS Society · cité 45 fois
• Community Engagement and Investment in Biomedical HIV Prevention Research for Youth: Rationale, Challenges, and Approaches
  2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes · cité 31 fois
• Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes
  2009 · BMC Public Health · cité 26 fois

Revues de publication

• Nature Communications × 2
• PLoS ONE × 2
• JAIDS Journal of Acquired Immune Deficiency Syndromes × 2
• The Lancet Respiratory Medicine × 1
• EClinicalMedicine × 1
• BMC Infectious Diseases × 1

Publications par année

• 20261
• 20241
• 20233
• 20191
• 20182
• 20172
• 20141
• 20131
• 20101
• 20091

Collaborations

Établissements partenaires : HJF Medical Research International · Walter Reed Army Institute of Research · United States Army · Universidad Peruana Cayetano Heredia · Moi University

Pays des co-auteurs : États-Unis · Thaïlande · Malawi

Co-auteurs

• Douglas Shaffer
• Margaret Bii
• William Kiplagat Sugut
• Isaac Tsikhutsu
• Josphat Kosgei
• Margret Bii
• Abraham Mosigisi Siika
• Ignatius N. Kiptoo
• Fredrick Kirui
• Umesh Lalloo
• Carolyne Sigei
• Eduardo Gotuzzo

Données bibliographiques issues d’OpenAlex (base ouverte).